Everything below concerns NAD+. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-09-30. Numbers and descriptions here follow the published literature rather than marketing material.
In the salvage pathway, NMN is generated from nicotinamide and 5-phosphoribosyl-1-pyrophosphate by the enzyme nicotinamide phosphoribosyltransferase. A second route produces NMN from nicotinamide riboside through phosphorylation by nicotinamide riboside kinases. NMN is then converted to NAD+ by nicotinamide mononucleotide adenylyltransferases, often called NMNAT enzymes. This stepwise route allows cells to recycle nicotinamide and maintain NAD+ levels under changing metabolic conditions. The relative contribution of each route varies by tissue, species, and physiological state, and it remains an active area of research.
Research on NMN has expanded because NAD+ concentrations decline with age in some tissues and because NAD+ participates in energy metabolism, DNA repair, and signaling. Animal studies have reported changes in NAD+ levels after NMN administration, but human data are more limited and often focus on safety, pharmacokinetics, and biomarker changes. Questions remain about oral absorption, tissue distribution, and whether changes in blood NAD+ reflect changes inside specific organs. NMN is not an approved drug, and claims about its clinical effects should be distinguished from established biochemical findings.
Nicotinamide mononucleotide, abbreviated NMN, is a nucleotide composed of nicotinamide, ribose, and phosphate. Its structure links nicotinamide to D-ribose 5-phosphate through a glycosidic bond, placing it in the pyridine nucleotide family. The compound exists in alpha and beta anomeric forms, and the beta form is the one used in NAD+ biosynthesis. NMN is not a protein or a hormone; it is a small water-soluble molecule that occurs in living cells as a metabolic intermediate.
Natural sources of NMN include mammals, plants, and microorganisms, where it functions as an intermediate in NAD+ salvage and biosynthesis pathways. In mammals, the enzyme nicotinamide phosphoribosyltransferase produces NMN from nicotinamide and phosphoribosyl pyrophosphate. NMN is then converted to NAD+ by nicotinamide mononucleotide adenylyltransferase. Some foods contain measurable NMN, but reported amounts vary widely by species, tissue, and analytical method. The extent to which dietary NMN contributes to cellular NAD+ pools remains an open research question.
| Property | Value | Notes |
|---|---|---|
| Chemical formula | C11H15N2O8P | Pyridinium nucleotide; free acid form |
| Molar mass | 334.22 g/mol | Free acid; salt forms differ |
| Appearance | White to off-white powder | Typical reference material |
| Solubility class | Water-soluble | Hygroscopic under humid conditions |
| Common synonyms | Nicotinamide mononucleotide; NMN | Distinct from nicotinamide riboside |
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide found in cells. Its structure combines a nicotinamide ring, a ribose sugar, and a phosphate group. As an intermediate in the NAD+ salvage pathway, NMN is converted to nicotinamide adenine dinucleotide, a coenzyme central to cellular redox reactions. NAD+ also serves as a substrate for enzymes involved in DNA repair, stress responses, and metabolic regulation. The compound is therefore part of normal cellular biochemistry rather than an exclusively synthetic molecule.
Two enzymatic steps define the canonical route from nicotinamide to NAD+. Nicotinamide phosphoribosyltransferase, known as NAMPT, produces NMN from nicotinamide and phosphoribosyl pyrophosphate. NMN adenylyltransferases, or NMNAT enzymes, then couple NMN with ATP to form NAD+. Whether intact NMN crosses cell membranes efficiently remains an active area of investigation; some studies propose direct transport, while others emphasize extracellular dephosphorylation to nicotinamide riboside followed by uptake. The relative contribution of each route likely depends on cell type, tissue, and experimental conditions.
Trace amounts of NMN have been reported in certain plant foods, including edamame, avocado, broccoli, cucumber, and cabbage. Reported concentrations vary widely because analytical methods differ and food matrices complicate extraction. Endogenous production in cells is generally considered more quantitatively important than dietary intake, though precise human turnover rates are difficult to establish. Commercial NMN for research or consumer products is commonly made through enzymatic synthesis or chemical phosphorylation routes. Regulatory classification differs by country; in some jurisdictions NMN is sold as a supplement, while in others it is treated as a novel food ingredient or restricted substance.
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide. Its structure combines a nicotinamide base with a ribose sugar and a phosphate group. Within cells, NMN sits on the biosynthetic route that recycles nicotinamide back into nicotinamide adenine dinucleotide, or NAD+. Because NAD+ participates in redox reactions and signaling, enzymes that produce and consume it influence many metabolic processes. The compound is therefore best described as an intermediate rather than a final signaling molecule.
In the canonical salvage pathway, nicotinamide phosphoribosyltransferase, known as NAMPT, transfers a phosphoribosyl group to nicotinamide and releases NMN. A second enzyme, NMN adenylyltransferase, then attaches an adenylyl group to NMN to form NAD+. Alternative routes exist, including a pathway that uses nicotinamide riboside and its phosphorylated forms. The relative contribution of extracellular NMN to intracellular NAD+ pools remains an area of active investigation, and the roles of specific transporters and enzymes are not completely defined.
NAD+ serves as a coenzyme in redox reactions and as a substrate for enzymes involved in DNA repair and cellular signaling. In the salvage pathway, nicotinamide is converted to NMN by the enzyme NAMPT. NMN is then converted to NAD+ by NMNAT enzymes. A separate route links nicotinamide riboside to NMN through phosphorylation. These pathways maintain NAD+ levels, which can decline with age or metabolic stress in some tissues. The relative contribution of circulating NMN to tissue NAD+ remains an active area of study.
Research on NMN includes cell studies, animal experiments, and a growing number of human trials. Many early findings come from mice, where changes in NAD+ levels and metabolic markers have been reported. Human data are more limited, and questions remain about effective routes of administration, tissue distribution, and long-term effects. Some trials measure NAD+ in blood or tissue, while others assess physical function or metabolic outcomes. Regulatory status differs between countries, and NMN is not universally approved as a dietary supplement or therapeutic agent.
Metal-binding proteins are proteins or protein domains that chelate a metal ion. They are a subgroup of metalloproteins. Binding of metal ions via chelation is usually achieved via histidines or cysteines. In some cases this is a necessary part of their folding and maintenance of a tertiary structure. Alternatively, a metal-binding protein may maintain its structure without the metal (apo form) and bind it as a ligand (e.g. as part of metal homeostasis). In other cases a coordinated metal cofactor is used in the active site of an enzyme to assist catalysis.
=== Coarse-graining and reduced representations === At the other end of the detail scale are coarse-grained and lattice models. Instead of explicitly representing every atom of the system, one uses "pseudo-atoms" to represent groups of atoms. MD simulations on very large systems may require such large computer resources that they cannot easily be studied by traditional all-atom methods. Similarly, simulations of processes on long timescales (beyond about 1 microsecond) are prohibitively expensive, because they require so many time steps. In these cases, one can sometimes tackle the problem by using reduced representations, which are also called coarse-grained models. Examples for coarse graining (CG) methods are discontinuous molecular dynamics (CG-DMD) and Go-models. Coarse-graining is done sometimes taking larger pseudo-atoms. Such united atom approximations have been used in MD simulations of biological membranes. Implementation of such approach on systems where electrical properties are of interest can be challenging owing to the difficulty of using a proper charge distribution on the pseudo-atoms. The aliphatic tails of lipids are represented by a few pseudo-atoms by gathering 2 to 4 methylene groups into each pseudo-atom. The parameterization of these very coarse-grained models must be done empirically, by matching the behavior of the model to appropriate experimental data or all-atom simulations. Ideally, these parameters should account for both enthalpic and entropic contributions to free energy in an implicit way.
== J == Nancy B. Jackson (1956–2022), American chemist who worked on heterogeneous catalysis and the development of alternative fuels Marilyn E. Jacox (1929–2013), American chemist who worked on the spectroscopy of free radicals and other unstable chemical species Hope Jahren (born 1969), American chemist and isotope analyst known for using stable isotope analysis to analyze fossil forests Paul Janssen (1926–2003), Belgian physician and entrepreneur who discovered the antispasmodic drug ambucetamide Allene Jeanes (1906–1995), American chemist who developed Dextran to replace plasma in the Korean War Frédéric Joliot-Curie (1900–1958), French chemist and physicist, 1935 Nobel Prize in Chemistry for the discovery of induced radioactivity Irène Joliot-Curie (1897–1956), French chemist and physicist, 1935 Nobel Prize in Chemistry for the discovery of induced radioactivity Madeleine M. Joullié (born 1927), French-American-Brazilian organic chemist who worked on synthesizing organic compounds such as tilorone, furanomycin, and numerous cyclopeptides Percy Lavon Julian (1899–1975), African American organic chemist who was a pioneer in the chemical synthesis of medicinal drugs from plants. He was the first to synthesize the natural product physostigmine.
Sources: en.wikipedia.org
At the 2015 China Victory Day Parade, Xi announced a reduction of 300,000 troops from the PLA, bringing its size to 2 million troops. Xi described this as a gesture of peace, while analysts have said that the cut was done to reduce costs as well as to modernize the PLA. In November 2015, the Central Leading Group for Military Reform announced extensive reforms in the PLA called Deepening National Defense and Military Reform. In 2016, Xi reduced the number of theater commands of the PLA from seven to five. He also abolished the four autonomous general departments of the PLA, replacing them with 15 agencies directly reporting to the CMC. Two new branches of the PLA were created under his reforms, the Strategic Support Force and the Joint Logistics Support Force. PLA Second Artillery Corps was upgraded to the PLA Rocket Force. In March 2016, the CMC announced the abolishment of paid services by the PLA and the People's Armed Police (PAP) by 2019, meaning activities like military-run hospitals and hotels open to the public. On 21 April 2016, Xi was named commander-in-chief of the country's new CMC Joint Operations Command Center. In 2018, the PAP was placed under the sole control of the CMC; it was previously under the joint command of the CMC and the State Council through the Ministry of Public Security. The PLA went through further extensive reforms in 2024; the Strategic Support Force was dissolved and the Aerospace Force, the Cyberspace Force and the Information Support Force was established as arms of the PLA, joining the Joint Logistics Support Force.
Spherical cell cultures are another method developed around the ability of DMF to deliver droplets to cells. Application of an electric potential allows for automation of droplet transfer directly to the hanging cell culture.] This is beneficial as 3 dimensional cell culture and spheroids better mimic in vivo tissue by allowing for more biologically relevant cultures that have cells growing in an extracellular matrix similarly resembling that in the human body. Another use of DMF platforms in cell culture is its ability to conduct in vitro cell-free cloning using single molecule PCR inside droplets. PCR amplified products are then validated by transfection into yeast cells and a Western blot protein identification. Problems arising from cell culture applications using DMF include protein adsorption to the device floor, and cytotoxicity to cells. To prevent adsorption of protein to the platform's floor, a surfactant stabilized Silicon oil or hexane was used to coat the surface of the device, and droplets were manipulated atop of the oil or hexane. Hexane was later rapidly evaporated from cultures to prevent a toxic effect on cell cultures. Another approach to solve protein adhesion is the addition of Pluronic additives to droplets in the device. Pluronic additives are generally not cytotoxic but some have been shown to be harmful to cell cultures. Bio-compatibility of device set up is important for biological analyses.
=== Frabelle Fishing Corporation === Tiu Laurel became the president of the Frabelle Fishing Corporation in 1985 and its director in 2010. The family-owned business, which was established by Tiu Laurel's parents in 1966, is engaged in a variety of business interests in the agricultural and fisheries industry, such as deep-sea fishing, aquaculture, canning, meat and seafood processing, cold-chain network, shipbuilding and repair, and power generation. Frabelle operates in the Asia-Pacific region and supplies domestically in the Philippines and internationally. Concurrently, Tiu Laurel served as President of the Confederation of the Philippine Tuna Industry from 2002 to 2006, director of the Interland Deep Sea Fishing Sector, director of the World Tuna Purse Seine Organization, and chairman of the Processing Sector of Bangus (Milkfish) Council of the Philippines.
Sources: en.wikipedia.org
Niacin is incorporated into multi-vitamin and sold as a single-ingredient dietary supplement. The latter can be immediate or slow release. Nicotinamide is used to treat niacin deficiency and for supplementation because it does not cause the flushing adverse reaction seen with nicotinic acid. Nicotinamide may be toxic to the liver at doses exceeding 3 g/day for adults. One form of dietary supplement sold in the US is inositol hexanicotinate (IHN), also called inositol nicotinate. This is inositol that has been esterified with niacin on all six of inositol's alcohol groups. IHN is usually sold as "flush-free" or "no-flush" niacin in units of 250, 500, or 1000 mg/tablets or capsules. In the US, it is sold as an over-the-counter formulation, and often is marketed and labeled as niacin, thus misleading consumers into thinking they are getting an active form of the medication. While this form of niacin does not cause the flushing associated with the immediate-release products, there is not enough evidence to recommend IHN to treat hyperlipidemia.
Lifestyle modification (such as weight loss and exercise) and pain medications are the mainstays of treatment. Acetaminophen (also known as paracetamol) and NSAIDs (available as oral or topical formulations) are first line pain medications for symptomatic treatment of osteoarthritis. Medications that alter the course of the disease have not been found as of 2025. For overweight people, weight loss may help relieve pain due to hip arthritis. Recommendations include modification of risk factors through weight loss, increasing physical activity or exercise, healthy diet, management of contributing co-morbidities and adjustment of occupational factors that may contribute to osteoarthritis. Successful management of the condition is often made more difficult by differing priorities and poor communication between clinicians and people with osteoarthritis. Realistic treatment goals can be achieved by developing a shared understanding of the condition, actively listening to patient concerns, avoiding medical jargon, and tailoring treatment plans to the patient's needs. Recent research suggests that remote peer mentorship may help to improve self-management among people with hip or knee osteoarthritis who are experiencing socioeconomic disadvantage.
Hamburger, Cheeseburger, Double Cheeseburger, Triple Cheeseburger Big Hit (Big Mac) and Double Big Hit Grand Burger (Quarter Pounder with Cheese / McRoyal), Double Grand Burger, Grand Deluxe Burger (Quarter Pounder with Cheese Deluxe), Grand Deluxe jalapeño Big Special (Big Tasty), Double Big Special, Big Special Junior, Big Special with Mushrooms and Big Chicken Burger (Big Tasty Chicken) Fishburger (Filet-O-Fish) and Double Fishburger Chickenburger (Junior Chicken), Chicken Hit (McChicken), Chicken Hit, Chicken Premier (Seriously Chicken) and Chicken Premier with Mushrooms Caesar Roll (McWrap), Big Special Roll, Shrimp Roll, Fresh Roll and Chicken Fresh Roll French Fries / Grand Fries, Potato wedges and Potato slices Chicken nuggets, chicken strips, Fish Sticks, shrimp, apple slices and carrot sticks Vegetable salad, Caesar salad and Caesar salad with shrimp Dobry Cola (Coca-Cola), Dobry Cola Zero Sugar (Coca-Cola Zero Sugar), Dobry Orange (Fanta), Dobry Lemon-Lime (Sprite), Lipton Ice Tea Lemon, Lipton Ice Tea Green, Lemonade Strawberry-Cactus, Sunrise Strawberry-Cactus, milkshake, sundae, Ice Deluxe (McFlurry), tea, coffee and juice Kids Combo (Happy Meal) Breakfast pancakes, omelet, cherry pie and mango-passion fruit pie
Sources: en.wikipedia.org
NMN stands for nicotinamide mononucleotide. It is a naturally occurring nucleotide and an intermediate in the cellular production of NAD+.
No. NMN is a smaller precursor molecule, while NAD+ is a dinucleotide cofactor used in many reactions. Enzymes called NMNAT convert NMN into NAD+ inside cells.
This question is not fully settled. Some evidence suggests NMN may be dephosphorylated to nicotinamide riboside before uptake, while other studies propose direct transport. Tissue-specific handling in humans remains an open research area.
NMN stands for nicotinamide mononucleotide. It is a naturally occurring nucleotide and an intermediate in NAD+ biosynthesis.